Determining fitness for enfortumab vedotin and pembrolizumab in metastatic bladder cancer: the time to move beyond isolated comorbidity assessments
- B M Russell 1, D E C Fein 1, J Bellmunt 2
- B M Russell 1, D E C Fein 1, J Bellmunt 2
- 1Beth Israel Deaconess Medical Center, Boston, USA.
- 2Dana Farber Cancer Institute, Boston, USA.
- 0Beth Israel Deaconess Medical Center, Boston, USA.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.

